These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2008-006421-13||Multicenter Phase II Study: Bendamustine plus Bortezomib plus Dexamethasone in the treatment of stage II/III relapsed or refractory multiple myeloma||2013-12-17||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2008-006497-15||Lenalidomide and Dexamethasone for treatment of patients with acute myeloma (light chain)-induced renal failure||2014-09-15||bad-data|